Yea Christopher bought KALV
November 20, 2025 · Form 4 insider transaction
Yea Christopher bought 87,390 shares of KalVista Pharmaceuticals Inc at $0.00 per share, a transaction worth $375.78. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
87,390
Price
$0.00
Total value
$375.78
InsiderYea Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 20, 2025
Filing dateNovember 21, 2025
Shares owned after220,964
OwnershipDirect
10b5-1 planNo
AmendedNo